Tag: GlaxoSmithKline plc

  • Health Stocks In NewS: GlaxoSmithKline plc (NYSE:GSK), Abbott Laboratories (NYSE:ABT), Johnson & Johnson (NYSE:JNJ), Teva Pharmaceutical Industries (NYSE:TEVA), Bayer AG (OTCMKTS:BAYRY)

    UK pharmaceutical firm GlaxoSmithKline plc (ADR) (NYSE:GSK) has agreed to pay $105m to settle allegations that it illegally promoted its asthma drug Advair, and anti-depressant drugs Paxil and Wellbutrin. GlaxoSmithKline plc (ADR) (NYSE:GSK) net profit margin is 27.60% and weekly performance is -0.44%. On last trading day company shares ended up $53.70. Analysts mean target price for the company is $60.33. GlaxoSmithKline plc (ADR) (NYSE:GSK) distance from 50-day simple moving average is -0.07%.

    Abbott Laboratories (NYSE:ABT)‘s stock had its “neutral” rating reiterated by Zacks in a research report issued to clients and investors on Friday. They currently have a $42.00 price objective on the stock.Abbott Laboratories (NYSE:ABT) shares fell -0.25% in last trading session and ended the day on $40.05. ABT Gross Margin is 54.00% and its return on assets is 6.90%. Abbott Laboratories (NYSE:ABT) quarterly performance is 1.80%.

    Chicago has sued Johnson & Johnson (NYSE:JNJ), Actavis and three other drug companies for allegedly pushing consumer use of opioid painkillers, creating addicts and driving up its costs. Johnson & Johnson (NYSE:JNJ) shares moved down -0.04% in last trading session and was closed at $103.18, while trading in range of $102.84-$103.33. Johnson & Johnson (NYSE:JNJ) year to date performance is 14.25%.

    Teva Pharmaceutical Industries Ltd (NASDAQ:TEVA)‘s stock had its “neutral” rating restated by Zacks in a research note issued on Monday. They currently have a $53.00 target price on the stock.Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) ended the last trading day at $51.08. Company weekly volatility is calculated as 2.07% and price to cash ratio as 53.13. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) showed a positive weekly performance of 1.17%.

    German drug and chemicals maker Bayer AG (ADR) (OTCMKTS:BAYRY) said it appointed Dieter Weinand, a U.S.-based executive at Japanese drugmaker Otsuka, as the new head of its prescription drugs unit Bayer Healthcare Pharmaceuticals. Bayer AG (ADR) (OTCMKTS:BAYRY) On last trading day company shares ended up $143.51.